Liver Cancer Registry Platform
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cholangiocarcinoma
- Hepatocellular Carcinoma (HCC)
- Design
- Observational Model: OtherTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
JADE is a national, observational, prospective, longitudinal, multicenter cohort study (tumor registry platform) with the purpose to record information on the antineoplastic treatment of HCC or CCC in Germany. The registry will follow patients for up to three years. It will identify common therapeut...
JADE is a national, observational, prospective, longitudinal, multicenter cohort study (tumor registry platform) with the purpose to record information on the antineoplastic treatment of HCC or CCC in Germany. The registry will follow patients for up to three years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Health-related quality of life in patients with HCC / CCC will be evaluated for up to three years.
Tracking Information
- NCT #
- NCT04510740
- Collaborators
- Not Provided
- Investigators
- Study Chair: Thomas Berg, Prof.Dr. Leipzig Study Chair: Peter R. Galle, Prof.Dr. Mainz Study Chair: Wolf P. Hofmann, Prof.Dr. Berlin Study Chair: Achim Kautz Köln Study Chair: Philippe Pereira, Prof.Dr. Heilbronn Study Chair: Karin Potthoff, Dr. Freiburg im Breisgau Study Chair: Jan Schröder, PD Dr. Mülheim an der Ruhr Study Chair: Robert Thimme, Prof.Dr. Freiburg im Breisgau
Get Well Soon